RecruitingNCT04206852

Safety and Efficacy of Balloon Pulmonary Angioplasty in China

Sponsor

Chinese Pulmonary Vascular Disease Research Group

Enrollment

200 participants

Start Date

May 11, 2018

Study Type

OBSERVATIONAL

Conditions

Chronic Thromboembolic Pulmonary Hypertension

Summary

Balloon pulmonary angioplasty (BPA) is a potential treatment for non-operable patients with chronic thromboembolic pulmonary hypertension (CTEPH). The aim of this study was to evaluate the safety and efficacy of BPA in CTEPH patients not amenable to pulmonary endarterectomy(PEA) or suffered from persistent CTEPH after PEA.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is examining the safety and effectiveness of balloon pulmonary angioplasty (a procedure to open blocked blood vessels in the lungs) for Chinese patients with chronic thromboembolic pulmonary hypertension (CTEPH), a condition where old blood clots cause high blood pressure in the lung arteries. **You may be eligible if...** - You have been diagnosed with CTEPH (high blood pressure in the lungs due to old blood clots) - You have been on blood thinners for at least 3 months - You are not a candidate for surgical removal of the clots (pulmonary endarterectomy) - You are willing to provide informed consent **You may NOT be eligible if...** - You are unwilling or unable to provide written consent - You cannot attend follow-up visits Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBalloon pulmonary angioplasty

Balloon pulmonary angioplasty is an interventional technique where a balloon catheter is used to recanalize affected segments of pulmonary arteries identified during angiography.